Morimoto et al. have demonstrated that the expression of VEGFR1 and VEGFR2 on tumor cells and immunosuppressive tumor-microenvironment were positively correlated with tumor growth and recurrent in patients with chordomas [22]. Here, FLT1 is linked to neoplasm.